High avidity cytotoxic T lymphocytes to a foreign antigen are efficiently activated following immunization with a recombinant paramyxovirus, simian virus 5

Journal of General Virology

Volumn 83, Issue 5, 2002, Pages 1167-1172

  Parks, Griffith D ^a   Alexander Miller, Martha A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; OVALBUMIN; VIRUS ANTIGEN; VIRUS VACCINE; VIRUS VECTOR;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ENGINEERING; IN VIVO STUDY; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; SIMIAN VIRUS; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALIA; GALLUS GALLUS; PARAMYXOVIRIDAE; SIMIAE; SIMIAN PARAINFLUENZA VIRUS 5; VACCINIA VIRUS;

EID: 0036255967     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-5-1167     Document Type: Article

References (31)

1. d-restricted cytotoxic T lymphocytes
2. Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection
3. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy
4. Sequence comparison between the haemagglutinin-neuraminidase genes of simian, canine and human isolates of simian virus 5
5. Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus
6. Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor
7. New viral vectors for HIV vaccine delivery
8. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector
9. T cell responses to the paramyxovirus simian virus 5: Studies in multiple sclerosis and normal populations
10. Site of antigen delivery can influence T cell priming: Pulmonary environment promotes preferential Th2-type differentiation
11. Genetic manipulation of non-segmented negative-strand RNA viruses
12. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide
13. High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL
14. Early events in the biosynthesis of the lysosomal enzyme cathepsin D
15. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides
16. Does simian virus 5 infect humans?
17. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene
18. In defense of the lung: Paradoxical role of the pulmonary alveolar macrophage
19. Expression of rabies virus glycoprotein from a recombinant vaccinia virus
20. Paramyxoviridae: The viruses and their replication
21. Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases
22. Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen
23. New approaches for mucosal vaccines for AIDS: Encapsidation and serial passages of poliovirus replicons that express HIV-1 proteins on infection
24. Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus
25. Intracellular maturation and transport of the SV5 type II glycoprotein hemagglutinin-neuraminidase: Specific and transient association with GRP78-BiP in the endoplasmic reticulum and extensive internalization from the cell surface
26. RNA virus vectors: Where are we and where do we need to go?
27. Increased readthrough transcription across the simian virus 5 M-F gene junction leads to growth defects and a global inhibition of viral mRNA synthesis
28. Antigen processing in vivo and the elicitation of primary CTL responses
29. Attenuated vesicular stomatitis viruses as vaccine vectors
30. Recombinant rabies virus as potential live-viral vaccines for HIV-1
31. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity